Trials / Completed
CompletedNCT02019121
Dexmedetomidine and Renal Transplants
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 797 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine administration, these include (but are not limited to) UOP, Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will research both living and cadaveric renal transplants.
Conditions
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2020-02-01
- Completion
- 2020-02-01
- First posted
- 2013-12-24
- Last updated
- 2022-07-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02019121. Inclusion in this directory is not an endorsement.